Neuroscience News - AI, Neuroscience, Psychology Research

·April 9, 2020·2 min read

World-first trial to test benefit of intravenous zinc in COVID-19 fight

University of Melbourne researchers are conducting trials to see if intravenous administration of zinc chloride will help combat some of the effects of COVID-19. Previous studies have shown zinc is effective at slowing the rate of other respiratory infections, such as SARS.

Featured Neurology Neuroscience Open Neuroscience Articles

·April 9, 2020·3 min read

First in-human study of drug targeting brain inflammation supports further development

MW189, a small molecule drug candidate, blocks abnormal inflammation in the brain which contributes to injury and disease induced neurological impairments.

Featured Genetics Neuroscience Open Neuroscience Articles

·April 9, 2020·4 min read

Rare, damaging inherited mutations work together to reduce lifespan

People who have a high burden of ultra-rare protein-truncating variants (PTVs) have a shorter healthspan and lifespan. Each additional ultra-rare PTV in a person's genome accounted for a six-month reduction in lifespan and a two-month reduction in healthspan.

Featured Neuroscience

·April 8, 2020·3 min read

Periodic physical distancing for COVID-19 control: New modeling study

Mathematical model incorporated several strategies to help flatten the COVID-19 curve, focusing on scarcity in hospital resources over two years. The models showed current physical distancing can help maintain healthcare capacity and reduce infections. The model also allowed for periodic economic and psychological breaks from social restrictions.

Featured Neuroscience Open Neuroscience Articles

·April 8, 2020·5 min read

Protecting thin, flexible brain interfaces from the human body

Thin, flexible, next-generation of brain implants include more than a thousand electrodes and can survive for more than six years.

Featured Neuroscience Open Neuroscience Articles

·April 8, 2020·1 min read

Potential harms of chloroquine, hydroxychloroquine and azithromycin for treating COVID-19

Study warns of the potentially serious adverse effects of prescribing hydroxychloroquine and azithromycin for the treatment of COVID-19. Some of the potential side effects include cardiac arrhythmias, hypoglycemia, and neuropsychiatric effects.

Autism Featured Genetics Neuroscience Open Neuroscience Articles Psychology

·April 8, 2020·3 min read

Genes sow seeds of neuropsychiatric diseases before birth and in early childhood

Researchers identify genetic variations in the prefrontal cortex during different stages of development to assess how psychiatric conditions, such as autism and schizophrenia, may arise in individuals.

Featured Neuroscience Open Neuroscience Articles Psychology

·April 8, 2020·3 min read

False memories of crime appear real when retold to others

Study reveals people are only 53% likely to identify whether someone else in recounting and accurate or false memory of a crime.

Featured Neuroscience

·April 8, 2020·3 min read

Could a smartwatch identify an infection before you start spreading it?

A medical wrist device detected disrupted sleep patterns 24 hours before participants started shedding the flu virus. While the initial study was focused on influenza, researchers speculate the device could be sufficient at spotting the beginning of other infections, including COVID-19. While it should not be considered a full diagnostic device, the wristband data will be useful to guide when people should self isolate as a precaution.

This shows the word welcome written in different languages

Featured Neurology Neuroscience

·April 8, 2020·4 min read

Bilingualism Delays the Onset of Alzheimer’s Symptoms

People who spoke two or more languages proficiently were, on average, four years older at the onset of Alzheimer's disease than those who were monolingual.

This shows a depressed man holding up a picture of a sad face

Featured Genetics Neuroscience Open Neuroscience Articles Psychology

·April 8, 2020·3 min read

Key protein involved in the biology of depression identified

The GPR56 protein has been implicated in the biology of depression and a person's response to antidepressants.

Featured Neuroscience

·April 8, 2020·4 min read

Common coronaviruses are highly seasonal, with most cases peaking in winter months

Common coronaviruses are usually detected between December and May, with a peak of infection during January and February. Only 2.5% of cases occurred in the summer months. Researchers caution it is still too early to tell if COVID-19 will follow the same seasonal path as other coronaviruses.